Targeting cancer’s sweet spot: UGP2 as a therapeutic vulnerability

Sung-Hoon Kim, Andrew L. Wolfe, Sung Eun Kim, Sung Eun Kim

Molecular & Cellular Oncology · 2021 · 11 citations · 10 references

DOIFull text

Open access

Concepts

Abstract

Understanding the mechanisms governing metabolic reprogramming that underlie potential vulnerabilities in cancer cells is key to developing novel therapeutic strategies. The catalytic enzyme UDP-glucose pyrophosphorylase 2 (UGP2) drives the production of UDP-glucose. Our recent work demonstrated the crucial role of UGP2 in cancer growth and its regulation of cellular metabolic processes.

References

10